Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW677954 in overweight dyslipidaemic subjects
NCT00264667Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of saroglitazar in dyslipidemia, sponsored by GSK. Started Dec 2005; status: completed.
02
Drugs
saroglitazar
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00264667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00264667.